Amanote Research
Register
Sign In
Off-Label-Use in Der Onkologie: Keine Maximale, Sondern Optimale Medizin
Schweizerische Ärztezeitung
doi 10.4414/saez.2011.15939
Full Text
Open PDF
Abstract
Available in
full text
Date
April 6, 2011
Authors
Unknown
Publisher
EMH Swiss Medical Publishers, Ltd.
Related search
Ärzte Behandeln Keine Mittelwerte – Sondern Therapieresponder!
Schmerz
Medicine
Neurology
Anesthesiology
Pain Medicine
Off-Label-Therapie in Der Rheumatologie
Zeitschrift fur Rheumatologie
Rheumatology
Psychiatrie in Der Medizin – Psychotherapie in Der Medizin
Psychotherapie Forum
«Off Label Use»: Nouvelles Recommandations
Bulletin des Médecins Suisses
Off-Label Drug Use in Hospitalized Children
Archives of Pediatrics & Adolescent Medicine
Methylphenidate Off-Label Use and Safety
SpringerPlus
Multidisciplinary
Off-Label Use in Lymphoma Patients in Switzerland
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Off-Label Use of Approved Drugs
Nature Reviews Clinical Oncology
Oncology
Off-Label Use of Omalizumab in Pediatric Anaphylaxis
Journal of Allergy and Clinical Immunology
Allergy
Immunology